Close Many team members at Unicorn Nest are Ukrainians affected by Russian aggression. We do our best to solve any issues and answer your questions in the shortest possible time frames but some delays are possible.

IXO Private Equity

Investor type Private Equity Firm


Unlock datapoints

Portfolio analytics



News & Media

Add fund to favorites
Save this fund for later to form your own custom list of funds
This summary is composed by our algorithm based on the analysis of the deals. If you think that some of this information is not accurate, please let us know about it and provide any supporting evidences if possible. Such cases will be analyzed by our ML-algorithm and implemented in our database, which will improve this summary.

Looking for a perfect list of funds?

Get recommendations from our smart algorithm

Get the list
Total investments 50
Average round size
The average size of a deal this fund participated in
Portfolio companies 45
Rounds per year 1.19
Lead investments 7
Follow on index
How often the fund supports its portfolio startups at next rounds
Exits 9
Key employees 3
Stages of investment
Early Stage Venture
Late Stage Venture
Private Equity

Areas of investment

  • Manufacturing
  • Health Care
  • Biotechnology
  • Medical Device
  • Software

IXO Private Equity appeared to be the VC, which was created in 1981. The leading representative office of defined VC is situated in the Toulouse. The company was established in Europe in France.

The usual cause for the fund is to invest in rounds with 3-4 partakers. Despite the IXO Private Equity, startups are often financed by Partech, Elaia, Omnes Capital. The meaningful sponsors for the fund in investment in the same round are Partech, Elaia, Omnes Capital. In the next rounds fund is usually obtained by Bpifrance, Intel Capital, Elaia.

Besides them, we counted 3 critical employees of this fund in our database.

Besides, a startup needs to be aged 6-10 years to get the investment from the fund. The fund has no exact preference in a number of founders of portfolio startups. If startup sums 4 of the founder, the chance for it to be financed is low. Among the most popular portfolio startups of the fund, we may highlight SuperSonic Imagine, Pole Star, Ixaltis. For fund there is a match between the country of its foundation and the country of its the most frequent investments - France. Among the most successful fund investment fields, there are Biopharma, Medical Device.

The fund is constantly included in 2-6 investment rounds annually. The increased amount of exits for fund were in 2018. When the investment is from IXO Private Equity the average startup value is 100-500 millions dollars. Opposing the other organizations, this IXO Private Equity works on 12 percentage points less the average amount of lead investments. Considering the real fund results, this VC is 2 percentage points more often commits exit comparing to other organizations. The high activity for fund was in 2017. The common things for fund are deals in the range of 10 - 50 millions dollars.

Read more

Related Funds

Funds investing in previous rounds
These funds often invest in the rounds preceeding the rounds of IXO Private Equity:
Typical Co-investors
IXO Private Equity is more likely to invest in rounds together with the following funds:
There are no funds here. If we find new data, we will add it here.
Funds investing in following rounds
These funds have a tendency to invest in the following rounds after IXO Private Equity:
There are no funds here. If we find new data, we will add it here.

Funds with similar focus

Funds from France
Funds with similar focus located in France:
Funds with the same geo focus
Funds with similar geography of portfolio companies:
Funds doing lead investments
Funds with similar focus acting as lead investors:

Look at other 50 related and similar funds Collapse list
Fund NameLocation
Baby Let's Go China, Hangzhou, Zhejiang
Global Natural Resource Investments England, London, United Kingdom
Hasselblad Foundation Gothenburg, Sweden, Vastra Gotaland
Jun Capital China, Shanghai
Kramer Capital Partners Connecticut, Stamford, United States
MYFARM Japan, Kyoto, Kyoto Prefecture
Next Play Capital California, Redwood City, United States

Notable deals

CompanyIndustryRound SizeDateInvestorsLocation


Food and Beverage
Health Care
Natural Resources
$17M29 Nov 2022 France, Auvergne-Rhône-Alpes, France


Customer Service
Plastics and Rubber Manufacturing
Product Design
Supply Chain Management
20 Oct 2022 Rhone-Alpes, Provence-Alpes-Côte d'Azur, France

Glass Partners Solutions

12 Jul 2022 France, New Aquitaine, France

Mon Chasseur Immo

Real Estate
$11M10 May 2022 France, Auvergne-Rhône-Alpes, France


Health Care
07 Apr 2022 Provence-Alpes-Cote d'Azur, Provence-Alpes-Côte d'Azur, France

EP2C Energy

Project Management
26 Jan 2022 Balma, Midi-Pyrenees, France


Artificial Intelligence
Management Information Systems
Skill Assessment
$12M23 Nov 2021 Lyon, Auvergne-Rhône-Alpes, France


Risk Management
$7M06 Oct 2021 Paris, Ile-de-France, France


Machinery Manufacturing
$11M12 Jul 2021 Paris, Ile-de-France, France


  • No reviews are submitted yet.
Do you want more?
We provide dozens of additional datapoints about this fund.
Sign up and get access to full fund profile and advanced analysis.
Full team
Industries heatmap
Stages heatmap
Georgaphy breakdown
Portfolio analysis
Performance indexes
Latest highlights
Unlock all data
Do you represent IXO Private Equity?
Get access to manage this page
Get in touch
Found incorrect info? Let us know!

You can raise money with us faster

Get matched with relevant funds

Find decision makers data

Connect with investors by email

Remind me later
...and save more than 200 hours*
*-Our recommendation and outreach system saves up to 200 hours of founder time on fundraising for seed and series A+ startups
We use LinkedIn only to verify your account. We don't import or message your contacts, nor post on your behalf.
By creating an account, you agree to our Terms of Service and Privacy Policy.
Crunchbase icon

Content report

The following text will be sent to our editors: